Cipher Pharmaceuticals Stock Forward View - Unknown Technical Ratio
| CPH Stock | CAD 16.70 -0.58 -3.36% |
Cipher Pharmaceuticals's Shares Outstanding reference page covers the model's projected value and error measures derived from recent price data. This information is intended as reference material for analytical purposes.
The forecast reference data presented here for Cipher Pharmaceuticals reflects Shares Outstanding model output and is intended as reference material for analytical use. Shares Outstanding Analysis Today
Cipher Pharmaceuticals has current Shares Outstanding of 0.| Volatility | Backtest | Information Ratio |
Cipher Pharmaceuticals Trading Date Momentum
| On March 19 2026 Cipher Pharmaceuticals was traded for 16.70 at the closing time. The maximum traded price for the trading interval was 17.35 and the lowest daily price was 16.29 . The daily volume was recorded at 41.9 K. The volume of trading on 19th of March 2026 did not affect price variability. The overall trading delta to the closing price today is 3.89% . |
| Compare Cipher Pharmaceuticals to competition |
Other Forecasting Options for Cipher Pharmaceuticals
Investors evaluating Cipher at any level of experience must contend with the challenge of understanding Cipher Pharmaceuticals' price movement. The presence of noise in Cipher Stock price charts can significantly complicate investment decisions.Cipher Pharmaceuticals Related Equities
The following equities are related to Cipher Pharmaceuticals within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Cipher Pharmaceuticals against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Cipher Pharmaceuticals Market Strength Events
For investors tracking Cipher Pharmaceuticals, market strength indicators offer a quantitative way to evaluate how the stock behaves under varying market conditions. These metrics are widely used to refine market timing and identify the most favorable moments to trade Cipher Pharmaceuticals.
Cipher Pharmaceuticals Risk Indicators
Analyzing Cipher Pharmaceuticals' basic risk indicators provides investors with a structured view of the risk-return trade-off associated with cipher stock. Forecasting Cipher Pharmaceuticals' future price accurately requires understanding and quantifying the risks present in the investment.
| Mean Deviation | 1.73 | |||
| Semi Deviation | 1.42 | |||
| Standard Deviation | 2.87 | |||
| Variance | 8.25 | |||
| Downside Variance | 2.55 | |||
| Semi Variance | 2.02 | |||
| Expected Short fall | -2.45 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cipher Pharmaceuticals
A coverage review of Cipher Pharmaceuticals shows when the security is attracting above-average attention from contributors and market observers. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Cipher Pharmaceuticals Short Properties
Short sentiment tied to Cipher Pharmaceuticals matters because heavier bearish pressure can change how quickly future price expectations become unstable. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
| Common Stock Shares Outstanding | 26 M | |
| Cash And Short Term Investments | 7.5 M |
More Resources for Cipher Stock Analysis
Other Information on Investing in Cipher Stock
Financial ratios for Cipher Pharmaceuticals organize key financial data into structured relationships. They provide context across profit, cash flow, and overall value. This format maintains consistency across different reporting periods.